Can a Self-Management course ease Long-COVID symptoms?
NCT ID NCT06208696
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a Spanish-language chronic-disease self-management program called 'Tomando control de su salud' in 47 adults with Long-COVID and at least one other chronic condition in Puerto Rico. The goal was to see if the program could improve quality of life, reduce fatigue, and ease anxiety. Participants attended weekly sessions to build confidence in managing their health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Tomando control de su salud (Spanish Chronic Disease Self-Management Program)
- What this could lead to
- If successful, this program could offer a practical, low-cost way to help people with Long-COVID better manage their symptoms and improve daily life.
- What could go wrong
- This is a small pilot study with only 47 participants and no control group, so results may not apply broadly. The program is not a medical treatment and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
47 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Mar 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adult patients 21 years or older; 2. Participant of PR COAS-cohort that completed the last interview (12-month-follow-up) and authorized to be contacted for further studies; 3. Having at least one chronic condition (excluding cancer) diagnosed by a physician or healthcare provider, and 4. Ability to attend weekly sessions. Exclusion Criteria: 1. Any clinical or cognitive impairment that limits the participant's ability to decide to participate in the study or complete the interviews; 2. presence of a life threatening or extreme medical condition, and 3. planning to move out of the municipality within the next year.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Long COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Dotal de Investigaciones de Servicios de Salud, UPR-MSC (Hospital UPR)
Carolina, PR, 00984, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mindfulness may offer relief for long COVID sufferers
- Can magnetic pulses to the brain reverse Long-COVID smell loss, tinnitus, and fatigue?
- Can brain games and gentle currents lift long COVID brain fog?
- Brain fog after COVID: can a mental workout restore focus?
- Fish oil and Body's own healing molecules could lift long COVID depression
- Zapping the brain to clear long COVID fog: a new hope?